Corrigendum to "S100A9 maintains myeloid-derived suppressor cells in chronic sepsis by inducing miR-21 and miR-181b" [Mol. Immunol. 112 (August) (2019) 72-81].
Alkhateeb T, Kumbhare A, Bah I, Youssef D, Yao ZQ, McCall CE, Gazzar ME. Corrigendum to "S100A9 maintains myeloid-derived suppressor cells in chronic sepsis by inducing miR-21 and miR-181b" [Mol. Immunol. 112 (August) (2019) 72-81]. Mol Immunol. 2020 Nov; 127:78.